Author

Bianca Meesen

Observed names: B Meesen, B. Meesen, B. P. W. MEESEN, B. P. W. Meesen, Bianca P.W. Meesen, Meesen, Bianca

Observed institution: Utrecht University

OpenAlex ID: A5022940371

Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction – Triumph: The Role of General Practice Databases

2001 · John W. Logie, Gary M. Clifford, et al. · European Urology · 34

Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion

2005 · F C Lowe, J Batista, et al. · Prostate Cancer and Prostatic Diseases · 30

The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?

2016 · Patrick Vermersch, Thomas Berger, et al. · Multiple Sclerosis Journal · 26

The effect of testosterone and rutting on the metabolism and pharmacokinetics of sulphadimidine in goats

1988 · J. F. M. NOUWS, B. P. W. MEESEN, et al. · Journal of Veterinary Pharmacology and Therapeutics · 22

The payer’s perspective: What is the burden of MS and how should the patient’s perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment?

2016 · Ralf Gold, Mondher Toumi, et al. · Multiple Sclerosis Journal · 20

Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion

2011 · Bertrand Tombal, Filip Ameye, et al. · World Journal of Urology · 18

The effect of testosterone on the plasma disappearance rates of sulphadimidine and antipyrine in castrated dwarf goats

1986 · B. P. W. Meesen, E. J. M. van Deurzen, et al. · Veterinary Quarterly · 15

Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise

2005 · M Speakman, J Batista, et al. · Prostate Cancer and Prostatic Diseases · 12

The regulator’s perspective: How should new therapies and follow-on products for MS be clinically evaluated in the future?

2016 · Daan JA Crommelin, Karl Broich, et al. · Multiple Sclerosis Journal · 11

Relationship Between Patient-Reported Outcomes and Clinical Outcomes in Patients With Morquio A Syndrome

2015 · Christina Lampe, Mohit Jain, et al. · Journal of Inborn Errors of Metabolism and Screening · 11

The patient’s perspective: How to create awareness for improving access to care and treatment of MS patients?

2016 · Patrick Vermersch, Andreas Faller, et al. · Multiple Sclerosis Journal · 8

Prise en charge du cancer de la prostate : analyse rétrospective de 808 hommes biopsiés en France

2013 · O. Cussenot, F. Rozet, et al. · The French Journal of Urology · 6

Impact of Elosulfase Alfa on Pain in Patients with Morquio A Syndrome over 52 Weeks

2017 · Marsha Treadwell, Paul R. Harmatz, et al. · Journal of Inborn Errors of Metabolism and Screening · 5

233 Integrating risk profiles in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia. A systematic analysis of expert opinion

2004 · M. Speakman, R. Berges, et al. · European Urology Supplements · 4

Outcomes of a Physician Survey on the Type, Progression, Assessment, and Treatment of Neurological Disease in Mucopolysaccharidoses

2018 · Maurizio Scarpa, Paul R. Harmatz, et al. · Journal of Inborn Errors of Metabolism and Screening · 3

POD-02.07 Development of a Risk-Based Decision Model for Prostate CAncer Gene 3 (PCA3) Usage

2011 · M. Speakman, F. Ameye, et al. · Urology

Works count: 18

Citation count: 225

H-index: 10

I10-index: 10